Monica Musteanu

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 01, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

|Mar 14, 2026
Differential Effects of Apigenin on Normal and Squamous Oral Epithelial Cells Reveal Redox-Autophagy Signaling Vulnerabilities in OSCC.

Bianca Voicu Balasea, Miruna-Silvia Stan, Miruna Dinescu

|Feb 06, 2026
RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1.

Laura de-la-Puente-Ovejero, Ana Fernández-Rodríguez, Sarah Francoz

|Dec 02, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou

|Aug 26, 2024
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.

Fernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre

|Jul 24, 2021
KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform.

Marina Salmón, Guillem Paniagua, Carmen G Lechuga

Pageof 2